Correlation Between Vaxcyte and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vaxcyte and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxcyte and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Vaxcyte and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and Alnylam Pharmaceuticals.
Diversification Opportunities for Vaxcyte and Alnylam Pharmaceuticals
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Vaxcyte and Alnylam is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Vaxcyte i.e., Vaxcyte and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vaxcyte and Alnylam Pharmaceuticals
Given the investment horizon of 90 days Vaxcyte is expected to generate 1.43 times less return on investment than Alnylam Pharmaceuticals. In addition to that, Vaxcyte is 1.23 times more volatile than Alnylam Pharmaceuticals. It trades about 0.13 of its total potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about 0.23 per unit of volatility. If you would invest 24,055 in Alnylam Pharmaceuticals on November 9, 2024 and sell it today you would earn a total of 3,770 from holding Alnylam Pharmaceuticals or generate 15.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vaxcyte vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Vaxcyte |
| Alnylam Pharmaceuticals |
Vaxcyte and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaxcyte and Alnylam Pharmaceuticals
The main advantage of trading using opposite Vaxcyte and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Vaxcyte vs. Larimar Therapeutics | Vaxcyte vs. Syndax Pharmaceuticals | Vaxcyte vs. Merus BV | Vaxcyte vs. Sutro Biopharma |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |